Cargando…
Strategies to Overcome Heparins’ Low Oral Bioavailability
Even after a century, heparin is still the most effective anticoagulant available with few side effects. The poor oral absorption of heparins triggered the search for strategies to achieve oral bioavailability since this route has evident advantages over parenteral administration. Several approaches...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039490/ https://www.ncbi.nlm.nih.gov/pubmed/27367704 http://dx.doi.org/10.3390/ph9030037 |
_version_ | 1782456066957639680 |
---|---|
author | Neves, Ana Rita Correia-da-Silva, Marta Sousa, Emília Pinto, Madalena |
author_facet | Neves, Ana Rita Correia-da-Silva, Marta Sousa, Emília Pinto, Madalena |
author_sort | Neves, Ana Rita |
collection | PubMed |
description | Even after a century, heparin is still the most effective anticoagulant available with few side effects. The poor oral absorption of heparins triggered the search for strategies to achieve oral bioavailability since this route has evident advantages over parenteral administration. Several approaches emerged, such as conjugation of heparins with bile acids and lipids, formulation with penetration enhancers, and encapsulation of heparins in micro and nanoparticles. Some of these strategies appear to have potential as good delivery systems to overcome heparin’s low oral bioavailability. Nevertheless, none have reached the market yet. Overall, this review aims to provide insights regarding the oral bioavailability of heparin. |
format | Online Article Text |
id | pubmed-5039490 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-50394902016-10-04 Strategies to Overcome Heparins’ Low Oral Bioavailability Neves, Ana Rita Correia-da-Silva, Marta Sousa, Emília Pinto, Madalena Pharmaceuticals (Basel) Review Even after a century, heparin is still the most effective anticoagulant available with few side effects. The poor oral absorption of heparins triggered the search for strategies to achieve oral bioavailability since this route has evident advantages over parenteral administration. Several approaches emerged, such as conjugation of heparins with bile acids and lipids, formulation with penetration enhancers, and encapsulation of heparins in micro and nanoparticles. Some of these strategies appear to have potential as good delivery systems to overcome heparin’s low oral bioavailability. Nevertheless, none have reached the market yet. Overall, this review aims to provide insights regarding the oral bioavailability of heparin. MDPI 2016-06-29 /pmc/articles/PMC5039490/ /pubmed/27367704 http://dx.doi.org/10.3390/ph9030037 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Neves, Ana Rita Correia-da-Silva, Marta Sousa, Emília Pinto, Madalena Strategies to Overcome Heparins’ Low Oral Bioavailability |
title | Strategies to Overcome Heparins’ Low Oral Bioavailability |
title_full | Strategies to Overcome Heparins’ Low Oral Bioavailability |
title_fullStr | Strategies to Overcome Heparins’ Low Oral Bioavailability |
title_full_unstemmed | Strategies to Overcome Heparins’ Low Oral Bioavailability |
title_short | Strategies to Overcome Heparins’ Low Oral Bioavailability |
title_sort | strategies to overcome heparins’ low oral bioavailability |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039490/ https://www.ncbi.nlm.nih.gov/pubmed/27367704 http://dx.doi.org/10.3390/ph9030037 |
work_keys_str_mv | AT nevesanarita strategiestoovercomeheparinsloworalbioavailability AT correiadasilvamarta strategiestoovercomeheparinsloworalbioavailability AT sousaemilia strategiestoovercomeheparinsloworalbioavailability AT pintomadalena strategiestoovercomeheparinsloworalbioavailability |